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Membrane translocationCell-penetrating peptides (CPPs) can internalize into cells with covalently or non-covalently bound biologi-
cally active cargo molecules, which by themselves are not able to pass the cell membrane. Direct penetration
and endocytosis are two main pathways suggested for the cellular uptake of CPPs. Cargo molecules which
have entered the cell via an endocytotic pathway must be released from the endosome before degradation
by enzymatic processes and endosomal acidiﬁcation. Endosomal entrapment seems to be a major limitation
in delivery of these molecules into the cytoplasm. Bacteriorhodopsin (BR) asymmetrically introduced into
large unilamellar vesicles (LUVs) was used to induce a pH gradient across the lipid bilayer. By measuring
pH outside the LUVs, we observed light-induced proton pumping mediated by BR from the outside to the
inside of the LUVs, creating an acidic pH inside the LUVs, similar to the late endosomes in vivo. Here we stud-
ied the background mechanism(s) of endosomal escape. 20% negatively charged LUVs were used as model
endosomes with incorporated BR into the membrane and ﬂuorescein-labeled CPPs entrapped inside the
LUVs, together with a ﬂuorescence quencher. The translocation of different CPPs in the presence of a pH gra-
dient across the membrane was studied. The results show that the light-induced pH gradient induced by BR
facilitates vesicle membrane translocation, particularly for the intermediately hydrophobic CPPs, and much
less for hydrophilic CPPs. The presence of chloroquine inside the LUVs or addition of pyrenebutyrate outside
the LUVs destabilizes the vesicle membrane, resulting in signiﬁcant changes of the pH gradient across the
membrane.
© 2012 Published by Elsevier B.V.1. Introduction
Cell-penetrating peptides (CPPs) were ﬁrst introduced in the late
1980s by the discovery of the TAT peptide from the transactivator of tran-
scription (TAT) of human immunodeﬁciency virus type one (HIV-1)
[1–3]. Since then,many other peptideswith similar cell-penetratingprop-
erties were found and characterized [4–6]. Generally, CPPs are deﬁned as
short, partly hydrophobic and/or polybasic peptides with a net positive
charge at physiological pH [7,8]. The main characteristic is their abilityeriorhodopsin; Pyrenebutyrate,
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sevier B.V.to penetrate the cell membrane at low micromolar concentrations in
vivo without using any chiral receptors and without causing signiﬁcant
membrane damage. Moreover, they are capable of internalizing electro-
statically or covalently bound biologically active small or large cargoes,
such as drugs and gene modulating agents, with high efﬁciency and low
toxicity [7,9,10].
A variety of biological assays, biophysical methods and model sys-
tems have been utilized to study the cellular uptake and membrane
translocation mechanisms of CPPs. The mechanism by which they
enter cells has not been completely resolved. There is evidence for
both direct cell membrane penetration and endocytotic pathways in
internalization of CPPs [9,11,12]. Endocytosis and subsequent endosomal
escape are believed to be amajor uptake route for CPPs at low concentra-
tions and in the presence of cargoes [13–18]. On the other hand, most
CPPs may utilize two or more pathways depending on the experimental
conditions [19–21].
Endosomal entrapment is a major challenge for CPPs and their
cargoes that have entered the cells via an endocytotic pathway. For
example, they could be digested by lysosomal hydrolysis before
reaching a target. Increasing hydrophobicity of the complex is one way
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studies have used the lysosomotropic agent, chloroquine (CQ) as an
inhibitor of endosomal acidiﬁcation and/or an agent for lysosomal
membrane perturbation, in order to enhance the performance of a
CPP [23]. In addition, CQ is also applied to provide evidence for an endo-
cytotic pathway [24,25]. In other studies, the membrane interacting
compound pyrenebutyrate (PB) has been applied as an agent that
enhances the potency of a CPP [26–28], possibly by weakening the cell
membrane.
In the present work, the aim is to obtain information about the
background mechanism(s) of endosomal escape. For this purpose,
20% negatively charged large unilamellar vesicles (LUVs), encapsulat-
ing the CPP (labeled with the dye ﬂuorescein) and a ﬂuorescence
quencher (KI) were prepared as a model endosome by the extrusion
method. This method produces a relatively homogeneous solution of
unilamellar vesicles of 100 nm diameter into which asymmetric
insertion of the proton pumping protein bacteriorhodopsin (BR)
could be achieved using the detergent mediated reconstitution meth-
od [29]. When BR absorbs light, it pumps protons in a direction that
depends on the direction of protein insertion into the membrane,
generating a pH gradient across the membrane. We have previously
shown that in the presence of light, BR pumps proton from the out-
side to the inside of the LUVs, creating an acidic pH inside the vesicles
[30]. This transmembrane pH gradient has been used to model the
late endosomes similar to those existing in vivo.
Despite obvious similarities between CPPs, especially in their cat-
ionic nature, they have different physico-chemical characteristics
based on their peptide sequence and membrane binding properties.
According to these differences, they can be divided into three classes,
including I) primary amphipathic CPPs, such as transportan [31]
togetherwith its shorter analog transportan 10 (TP10) [32], II) interme-
diately amphipathic CPPs, such as penetratin [33], pVEC [4] and M918
[34], and III) non-amphipathic CPPs, such as R9 [6] and TAT(48–60)
[1,2,35]. Table 1 shows CPPs that have been included in this study
together with some of their physical properties. CPPs from class I like
TP10 could not be included in the pH gradient studies, since even at
low concentrations they cause leakage from vesicles [26] and they can-
not be entrapped inside the vesicles under the conditions employed
here.
The CPPs studied here are non-amphipathic CPPs (R9 and
TAT(48–60)) and intermediately amphipathic CPPs (M918 and pVEC).
R9 is a synthetic homopolyarginine [6] and like TAT(48–60), it belongs
to the non-amphipathic group of CPPs, but with less hydrophobicity
(Table 1). In the report from Guterstam et al. [26], direct penetration
is suggested for the hydrophilic, Arg-rich R9 and TAT(48–60) at high
concentrations of the counteranion, PB. However at lower concentra-
tions of PB, the R9mediated oligonucleotide (ON) translocation mainly
occurs byArg-inducedmacropinocytosis. In several other studies, punc-
tate cytoplasmic localization of labeled TAT(48–60) and R9 observed by
live cell imaging shows the participation of endocytosis in the uptake
mechanism [36–38].
pVEC is an intermediately amphipathic CPP, derived from themurine
vascular endothelial-cadherin (VE-cadherin) protein [4]. Treatment of
the cells with different endocytosis inhibitors, especially wortmannin,
efﬁciently suppresses the cellular uptake of pVEC, indicating the activityTable 1
Investigated CPPs together with their physical properties at physiological pH.
Peptide No. of
Arg
Average
hydrophobicitya
No. of
residues
Sequence
R9 9 2.58 9 RRRRRRRRR
TAT (48–60) 6 2.37 13 GRKKRRQRRRPPQ
pVEC 4 1.10 18 LLIILRRRIRKQAHAHSK
M918 7 0.93 22 MVTVLFRRLRIRRACGPPRVRV
a Average hydrophobicity calculated according to the values from vonHeijne's scale [54].of the clathrin dependent endocytotic pathway [39]. However, uptake at
low temperatures conﬁrms the presence of non-endocytotic pathways in
the pVEC uptake mechanism [40]. M918 is a novel CPP with 22 residues,
seven of thempositively charged. The effects of endocytosis inhibitors on
the cellular internalization conﬁrmed the presence of endocytotic path-
ways in the uptake mechanism [34]. Penetratin, a fragment of the
Antennapedia homeodomain with 16 residues is one of the most exten-
sively studied CPPs and was used in the ﬁrst study reporting on a pH
gradient dependent transport of a CPP [41]. It may be classiﬁed as an
intermediately amphipathic CPP [26]. The majority of reports on the
uptake mechanism of penetratin suggest that endocytosis is the major
route of uptake, both in the absence or presence of cargo molecules. On
the other hand, like for Arg-rich CPPs, different types of endocytotic
pathways for penetratin and its cargo conjugates have been reported
[15,17,37,38,42–45].2. Materials and methods
2.1. Materials
Zwitterionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3[phospho-rac-(1-glycer-
ol)] with a negative head-group at neutral pH (POPG), as well as BMP,
sn-(3-oleyl-2-hydroxy)-glycerol-1-phospho-sn-1'-(3'-oleyl-2'-hydrox-
y)-glycerol (ammonium salt) were purchased from Avanti Polar Lipids
(Alabaster, Alabama, USA) and were used without further puriﬁcation.
The detergent n-octyl-β-D-glucopyranoside (OG) was from Glycon Bio-
chemicals (Luckenwalde, Germany). PD-10 desalting columnswere pur-
chased fromGE Healthcare (Buckinghamshire, UK). Bio-Beads were from
BIO-RAD (California, USA). FITC (ﬂuorescein isothiocyanate) labeled R9
and TAT(48–60)were produced by Polypeptide Laboratories (Strasbourg,
France). FITC (ﬂuorescein isothiocyanate) labeled M918 and pVEC were
chemically synthesized by Fmoc (9-ﬂuorenylmethyloxycarbonyl)
solid-phase peptide synthesis (SPPS) at the Department of Neurochemis-
try, StockholmUniversity.Halobacterium salinarum strain S9was a gener-
ous gift from Professor Esteve Padrós (Universitat Autonoma de
Barcelona, Spain). Bacteriorhodopsin (BR) was produced and puriﬁed es-
sentially according to a published protocol [46].2.2. LUV preparation: extrusion method
LUVs were prepared by dissolving the phospholipids (zwitterionic
POPC and 20% negatively charged POPG) in chloroform to obtain a
homogeneous solution, whereafter the solvent was removed by evap-
oration under high vacuum for 3 h. The resulting dried lipid ﬁlm was
resuspended by addition of 20 mM potassium phosphate and
100 mM KCl at pH 7.2. This solution was vortexed for 10 min and
then subjected to ﬁve freeze–thaw cycles with liquid nitrogen to
reduce the lamellarity. Next, an Avanti manual extruder was used to
push the lipid solution 20 times through two polycarbonate ﬁlters
(100 nm pore size). This method gave unilamellar vesicles with
100 nm diameter [47]. The size and stability of the LUVs were exam-
ined with a dynamic light scattering (DLS) instrument.2.3. Preparation of ﬂuorescein-labeled CPPs-entrapping LUVs
In the buffer used for LUV preparation, a 20 μM ﬂuorescein-
labeled CPP together with 100 mM potassium iodide (KI) as a ﬂuores-
cence quencher was included. LUVs containing CPPs were made as
described in the previous section. KI was used to quench the ﬂuores-
cence of the entrapped peptide inside the vesicle and hence to mini-
mize the background ﬂuorescence intensity. Therefore any increase in
ﬂuorescence intensity should be due to the leakage of the labeled
peptide from the inside of the LUVs.
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tion method
The preparation of BR-reconstituted LUVs (BR-LUVs) consists of
three steps: vesicle solubilization, BR addition, and detergent removal.
After 5 to 10 min of the vesicle solubilization by the addition of the
detergent, n-octyl-β-D-glucopyranoside (OG), BR monomers resulting
from detergent solubilization of purple membrane (BR 1 mg/mL, OG
100 mM) were added to the solubilized LUV suspension and incubated
for another 5 to 10 min. The resulting suspension should be amixture of
BR/lipid/detergent vesicles and lipid/detergent micelles with the ﬁnal
concentrations of 2 μM, 4.3 mM, and 29 mM for BR, lipid, and deter-
gent, respectively. At this stage, BR may be incorporated into the vesi-
cles, which have been saturated and destabilized by the detergent.
The BR/lipid/detergent mixtures were kept at room temperature for
5 min to 15 min, and the detergent was then removed. Detergent
removal should best be performed in two steps: ﬁrst slightly wet
Bio-Beads (80 mg/mL)were directly added to the suspension. Themix-
ture was lightly stirred (around 400 rpm) at room temperature. After
3 h of incubation at room temperature, a second portion of beads was
added and mixed overnight with a small shaker and the rate of around
400 rpm to remove residual detergents. At the end, two PD-10 columns
were used to remove Bio-Beads, residual detergents, quencher and
labeled peptides from outside the LUVs. The ﬁnal buffer outside
contained 20 mM potassium phosphate and 100 mM KCl (pH 7.2). A
detailed protocol describing this method is published in [30].
2.5. pH measurements
The buffer outside the BR-LUVs solution was replaced by 120 mM
KCl pH 7.4, using a PD-10 column, like in our previous study [30]
when outside pH was measured. The pH outside the BR-LUVs solution
was measured in a cuvette equipped with a magnetic stirrer, using a
pH meter (Thermo Scientiﬁc model 320). The pH outside the vesicles
was recorded during the dark and under illumination by a 150 W
xenon arc lamp.
2.6. Fluorescence spectroscopy and CPP leakage study
To study the effect of a pH gradient on the CPP translocation abil-
ity from the LUVs, ﬂuorescence spectroscopy was used. Fluorescence
intensity was measured in a Horiba Jobin Yvon Fluorolog-3 spectrom-
eter using a 4∗10 mm quartz cuvette. The sample was excited at
494 nm, and its emission was scanned from 505 to 550 nm. All exper-
iments were run at 20 °C.
3. Results
To evaluate the effect of the transmembrane pH gradient on the
translocation abilities of different CPPs, the light sensitive proton
pump BR was incorporated into the membrane of 20% negatively
charged phospholipid LUVs composed of POPC and POPG. The vesicle
properties and pH gradient that can be established over the mem-
brane depend on vesicle composition in terms of phospholipid con-
tent. In this study POPC and POPG were selected since they have a
low gel–liquid transition temperature and produce stable vesicles
with a stable pH gradient under the conditions employed here. BMP
is a major negatively charged component of the biological endosome
membrane [48,49]. A lipid mixture approximately corresponding to
the endosomal membrane (50% PC, 20% PE, 10% PI and 20% BMP)
was also investigated in a vesicle model system for incorporating
BR, as well as a pure zwitterionic POPC vesicle model system. We
observed that a weaker pH gradient was induced in the latter systems
(Fig. 1A, B and C). These results suggest that the BR proton pumping is
less efﬁcient with these vesicles or the vesicles form less of a mem-
brane proton barrier compared to the POPG-containing ones.Upon illumination of the POPC/POPG LUVs, the measured pH
increased and reached a maximum for BR-LUVs without entrapped
peptides, which is consistent with an increase in the pH on the out-
side of the LUVs (Fig. 1A). BR-mediated proton pumping from the
outside to the inside of vesicles resulted in the establishment of an
acidic pH inside the LUVs.
20 μM ﬂuorescein-labeled CPP together with 100 mM KI as a ﬂuo-
rescence quencher was entrapped in the LUVs. In the dark, we
observed no changes in the background ﬂuorescence intensity for
all examined CPPs, indicating that there is no leakage of the peptides
out of the LUVs when there is no pH gradient across the membrane on
the time scale of a few hours. The escape of the encapsulated
ﬂuorescein-labeled CPP from the LUVs during exposure to light was
determined by measuring the ﬂuorescence intensity of the sample
after certain times of illumination and compared with the value of
the background intensity (or the intensity of the sample kept in the
dark). The time duration of illumination and darkness was selected
according to the amount of ﬂuorescence intensity changes for each
peptide. Repeated measurements in identically prepared samples
showed good reproducibility in the measurements of the relative
ﬂuorescence intensities measured with a particular peptide (Fig. S1).
Fluorescein free in solution or covalently attached to a peptide has
a strong pH dependent ﬂuorescence, showing decreased ﬂuorescence
towards lower pH (Fig. S2). Fluorescein was chosen as the peptide
ﬂuorescence label, since its pH dependence makes it suitable to dis-
tinguish between situations where the peptide remains inside the
vesicles (lower pH, exposed to the quencher, thus lower ﬂuorescence
upon proton pumping) and where the peptide escapes from the inte-
rior of the vesicles to the outside (higher pH, absence of quencher,
thus higher ﬂuorescence upon proton pumping). Of course there
may also be intermediate situations where the two effects more or
less can cancel one another. Experiments with the less pH sensitive
ﬂuorophore label, carboxytetramethylrhodamine (TMR), were also
attempted with some CPPs. However, the more hydrophobic rhoda-
mine seems to interact with the bilayer independent of the nature
of the peptide, giving rise to ﬂuorescence quenching. This made the
measurements of escaped peptides difﬁcult to evaluate.
3.1. Non-amphipathic CPPs
In the presence of light, the ﬂuorescence intensity decreased for
POPC/POPG vesicle-entrapped non-amphipathic ﬂuorescein-labeled
CPPs, R9 and TAT(48–60) (Fig. 2A and B). The effect is explained by
the decreased pH inside the LUVs after BR proton pumping, when
no or only a minor fraction of peptides leak to the outside of the
LUVs. KI (from 2 M stock solution) was added as a control to quench
the ﬂuorescence intensity of potential peptides outside the LUVs. Fig.
S3 shows Stern–Volmer plots of the KI-quenching of ﬂuorescence in-
tensity of LUVs containing labeled R9, in the absence and presence of
light, together with the free ﬂuorescein-labeled R9 in buffer. The plot
Fo/F versus concentration of KI (mM) showed an increase in the slope
for the sample under illumination. The results from ﬂuorescence
quenching experiments show that there is a small amount of peptides
outside the LUVs and thus available for the quencher, but the great
majority of the peptides should remain inside where the pH-decrease
effect was dominant. The small difference between R9 and TAT in ﬂuo-
rescence decrease kinetics during proton pumping may be associated
with a somewhat higher tendency for TAT to translocate across the
membrane.
3.2. Intermediately amphipathic CPPs
For the intermediately amphipathic CPPs M918 and pVEC, we
observed that illumination causes an increase of the ﬂuorescence
intensity (Fig. 3A and B). This observation indicates that certain
amounts of peptides are able to escape outside the LUVs in the presence
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Fig. 1. Membrane pH gradient experiment. The pH changes outside the BR reconstituted LUVs as a function of illumination time. Conditions: 20 mM potassium phosphate and
100 mM KCl buffer, pH 7.2 inside the LUVs, 120 mM KCl outside the LUVs, pH 7.4, 25 °C. A) Buffer and quencher inside the 20% negatively charged BR-LUVs composed of POPC
and POPG, B) buffer and quencher inside the zwitterionic LUVs composed of POPC, C) buffer and quencher inside the LUVs composed of 50% PC, 20% PE, 10% PI and 20% BMP D)
75 μM CQ and quencher inside the negatively charged BR-LUVs, and E) after addition of 50 μM PB from outside the negatively charged LUVs.
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age of the labeled peptide to the outside of the LUVs. However, the
increase of ﬂuorescence intensity is not permanent. It returned to
almost its background value in the dark. This is due to the proton leak-
age to the outside of the LUVs which lowers the pH and decreases the
ﬂuorescence intensity. The behavior of M918 and pVEC is similar to
that of penetratin in a previous light-driven proton pumping study
[41]. In a separate experiment measuring the ΔpH outside the
BR-LUVs, the hydrophobic CPP TP10 was applied to the outside of the
LUVs. 0.01 μM TP10 had no obvious effect on the pH gradient whereas
0.5 μM TP10 did not allow a reproducible pH gradient over the mem-
brane (data not shown).
3.3. Effects of membrane modiﬁcation agents on the pH gradient in
BR-LUVs
To investigate the effect of CQ on the pH gradient associatedwith BR
proton pumping, we prepared CQ (75 μM) encapsulated in 20% nega-
tively charged LUVs composed of POPC and POPG. BRwas reconstituted
into the 20% negatively charged LUVs through detergent-mediatedreconstitution method. Resulting LUVs with and without BR were char-
acterized using DLS instrument.
The increase of pH outside the LUVs was about 10 times less than
the value observed with the LUVs in the absence of CQ (Fig. 1D). In
the dark, pH again decreased, indicating that protons leaked out
across the membrane, reaching an equilibrium state.
The effect of adding PB from the outside of the vesicles resulted in
a short inward proton pumping of BR which continued by destabiliza-
tion of the membrane (Fig. 1E).
4. Discussion
After the methodological artifacts arising from cell ﬁxation process-
es had been eliminated from the studies, most CPPs have been found to
use endocytotic pathways, probably together with other competing
mechanisms, for their cellular internalization [50]. Endocytotic uptake
route is composed of two steps: 1) endocytotic entry; and 2) endosomal
escape. Apart from entry into the endosome, endosomal escape is
important to obtain any bioactivity effects of the cargo molecules. In
the present work, we aim to obtain information about the background
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modeled by LUVs with a 20% negative surface charge and integral BR
as a proton pump. Fluorescein-labeled CPPs were entrapped together
with a ﬂuorescence quencher (KI) inside the LUVs. In the previous
work we have shown that upon illumination, BR pumps protons into
the LUVs, creating a pH gradient over themembrane andmaking inside
the LUVs more acidic (about −2 pH units), similar to the late
endosomes in vivo [30]. In these experiments, the rate of peptide trans-
location associated with vesicle acidiﬁcation is on the order of 20 to
100 min comparable with the time course reﬂecting the endosomal es-
cape process within cells [51].
This study shows that the non-amphipathic and intermediately
amphipathic CPPs are not able to translocate across the POPC/POPG
vesicular membrane without any promoting pH gradients. Moreover,
in the presence of light, a pH gradient over the membrane has differ-
ent effects for the examined ﬂuorescein-labeled CPPs. For intermedi-
ately amphipathic peptides, M918 and pVEC, lowering the pH inside
the LUVs results in escape of the peptides into the external solution.
For non-amphipathic peptides, R9 and TAT(48–60), no or much less
peptide translocation across the membrane was observed in the pres-
ence of the pH gradient. For zwitterionic POPC vesicles, both groups of
peptides are unable to translocate across the membrane. This isprobably related to the weaker generated pH gradient over the mem-
brane compared with partly negatively charged vesicles (data not
shown).
At least two competing processes are present in the BR-LUVmodel
system during illumination: 1) BR proton pumping, which decreases
the pH inside the LUVs and hence decreases the ﬂuorescence intensi-
ty of ﬂuorescein present inside the LUVs; and 2) possible transloca-
tion of the peptides across the membrane to the outside of the
LUVs, which increases the ﬂuorescence intensity. The results show
that the proton gradient improves the vesicular escape efﬁciency of
intermediately amphipathic CPPs, indicating a dominating effect of
the second process. However, for non-amphipathic CPPs, the ﬁrst pro-
cess of pH drop inside the LUVs is more prominent.
The results indicate that the proton gradient applied in the present
experiments is not sufﬁcient to promote the escape across the vesicle
membrane for non-amphipathic (Arg-rich) CPPs and that they may
require more hydrophobicity to pass the membrane and escape
from the endosome [52,53]. These observations are in good agree-
ment with our previous mechanistic results observed in the presence
of PB [26]. We have shown that electrostatic interactions between
Arg-rich CPPs and PB enhanced their cellular uptake and cargo
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plex is more hydrophobic than the peptide itself. Also, based on our
previous results from membrane model leakage studies, hydropho-
bicity is the essential parameter in model membrane interactions as
seen for the hydrophobic and intermediately hydrophobic CPPs.
Non-amphipathic or hydrophilic CPPs like TAT(48–60) induce no or
less leakage compared with hydrophobic CPPs [26]. In the present
study, the more hydrophobic peptides may have a tighter association
with the membrane bilayer, and therefore be more sensitive towards
the pH gradient across the membrane. Whereas the calcein leakage
studies report on membrane perturbation by the peptides and the
present results suggest membrane association and translocation of
the peptide, both observations may have a similar molecular back-
ground in the peptide–membrane interaction.
CQ is a relatively hydrophobic weak base with two basic groups. It
can absorb protons, resulting in reduction of acidiﬁcation inside the
LUVs, but it can also cause membrane destabilization due to vesicle
swelling. Here we observed that in the presence of CQ inside the
LUVs, the pH increase outside the vesicle membrane is signiﬁcantly
lower than the value with LUVs in the absence of CQ (Fig. 1D). Since
we recorded the pH outside of the LUVs, the effect observed here
should be due to leakage of the protons to the outside of the LUVs
as a result of transient membrane destabilization by CQ. This mem-
brane destabilization effect is however relatively minor compared to
that of PB added to the vesicles from outside. It should be mentioned
that although PB has a strong effect on the pH gradient stabilization, it
does not cause leakage of entrapped calcein from similar LUVs [26].
In summary, this study gives further emphasis on hydrophobicity
as an important property to direct CPP mechanisms, since hydropho-
bicity has been shown to promote both general membrane leakage
[26] and now also pH gradient promoted vesicular escape for inter-
mediately amphipathic CPPs. An additional insight from the study is
that the endosomal model system (BR-reconstituted LUVs) used
here may also be useful for studies of the membrane proton transport
barrier and how it is affected by the presence of various barrier mod-
ulating agents, such as CQ or PB.Acknowledgements
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